Evaluation of Efficacy and Safety of Topical Cannabidiol (Canvert-M Produced by Alasht Pharmed co. Iran) in the Treatment of Migraine Attacks

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 16, 2025

Primary Completion Date

September 16, 2025

Study Completion Date

September 16, 2025

Conditions
Migraine Disorders
Interventions
COMBINATION_PRODUCT

Canvert-M (Produced by Alasht Pharmed co. Iran)

Canvert-M is a topical roll-on formulation that contains cannabidiol, peppermint, lavender, rosemary, eucalyptus, wintergreen, basil oil, etc. At the onset of a migraine attack, an adequate amount of Canvert-M roll-on should be applied to the areas of the forehead, temporal, behind the ears, and the base of the neck. If the patient's headache persists after 30 minutes, a second dose can be used.

Trial Locations (1)

Unknown

RECRUITING

Tehran Province, Tehran, Imam Khomeini Street (RA) - Before Hassan Abad Square, Tehran

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alasht Pharmed

INDUSTRY